Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival.

× No keyword cloud information.

14 in total

Review 1. Growth factors and renal cancer: characterization and therapeutic implications.

Authors: J H Mydlo
Journal: World J Urol Date: 1995 Impact factor: 4.226

2. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

Authors: J W Slaton; K Inoue; P Perrotte; A K El-Naggar; D A Swanson; I J Fidler; C P Dinney
Journal: Am J Pathol Date: 2001-02 Impact factor: 4.307

3. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.

Authors: Y Kakeji; B A Teicher
Journal: Invest New Drugs Date: 1997 Impact factor: 3.850

4. SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.

Authors: Changge Fang; Ingalill Avis; Caterina Bianco; Natalie Held; Jennifer Morris; Kris Ylaya; Stephen M Hewitt; Alfred C Aplin; Roberto F Nicosia; Laura A Fung; John D Lewis; William G Stetler-Stevenson; David S Salomon; Frank Cuttitta
Journal: Open J Clin Diagn Date: 2013-06

5. Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression.

Authors: M Aonuma; Y Saeki; T Akimoto; Y Nakayama; C Hattori; Y Yoshitake; K Nishikawa; M Shibuya; N G Tanaka
Journal: Int J Exp Pathol Date: 1999-10 Impact factor: 1.925

Expression of basic fibroblast growth factor in primary human renal tumors: correlation with poor survival.

Review 1. Growth factors and renal cancer: characterization and therapeutic implications.

2. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma.

3. Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.

4. SCNH2 is a novel apelinergic family member acting as a potent mitogenic and chemotactic factor for both endothelial and epithelial cells.

5. Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression.

6. Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas.

Review 7. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours.

8. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells.

9. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.

10. Novel methods for the determination of the angiogenic activity of human tumors.